TESTOSTERONE THERAPY, NEW OPPORTUNITIES IN DIABETES
MELLITUS

ANCA PANTEA-STOIAN 1#, SILVIU MIREL PIȚURU 2#*, RĂZVAN HAINĂROȘIE 3#, LILIANA FLORINA ANDRONACHE 4#, OCTAV GINGHINĂ 5#, CRISTIAN SERAFINCEANU 6,7#
1“Carol Davila” University OF Medicine and Pharmacy, Faculty of Medicine, Departament of Hygiene, 8 Eroii Sanitari
Street, Bucharest, Romania
2“Carol Davila” University of Medicine and Pharmacy, 37 Dionisie Lupu Street, Bucharest, Romania
3“Carol Davila” University of Medicine and Pharmacy, “Prof. Dr. Dorin Hociotă” Institute of Phonoaudiology and
Functional ENT Surgery, 21 Mihail Cioranu Street, Bucharest, Romania
4“Carol Davila” University of Medicine and Pharmacy, Department of Foreign Languages, 8 Eroii Sanitari Street,
Bucharest, Romania
5“Carol Davila” University of Medicine and Pharmacy, Faculty of Dental Medicine, Department of Surgery, “Sf. Ioan”
Clinical Emergency Hospital, 13 Vitan-Bârzești Road, Bucharest, RomaniaBucurești
6“N. C. Paulescu” National Institute of Diabetes, Nutrition and Metabolic Disease, 5-7 Ion Movilă Street, Bucharest,
Romania
7“Carol Davila" University of Medicine and Pharmacy, Department of Diabetes, Nutrition and Metabolic Diseases,
Bucharest, Romania
*corresponding author: piturus@yahoo.com
#All authors had equal contribution to this research.
DownloadDownload Full Article

Abstract:
Diabetes mellitus is at the moment a real public health problem worldwide. It is estimated that at least one-third of male
patients with type 2 diabetes mellitus also have associated testosterone deficiency. In this context, the opportunity for
testosterone medication in patients with hypogonadism and type 2 diabetes mellitus becomes very attractive if we also take
into account its pleiotropic effects on the metabolic syndrome. As it has been demonstrated, the low level of testosterone is
associated with an increase in cardio-metabolic risks, which lead to increased premature mortality. Testosterone therapy is
relatively safe, having potential benefits as long as the cases are carefully selected and its positive effects on the metabolic
status recommend this therapy as an interesting option in patients with documented diabetes mellitus and hypogonadism.






Top